DaBomb Protein Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	132.17	253.59	379.99	195.18	197.14
Trading Asset Securities	-	-	0.08	-	-
Cash & Short-Term Investments	132.17	253.59	380.07	195.18	197.14
Cash Growth	-47.88%	-33.28%	94.73%	-0.99%	-25.78%
Accounts Receivable	39.97	32.28	51.25	36.99	56.04
Other Receivables	2.12	2.76	1.08	1.44	1.07
Receivables	42.09	35.05	52.34	38.42	57.11
Inventory	19.05	34.07	20.23	52.79	37.68
Prepaid Expenses	3.9	3.87	4.89	19.54	39.97
Other Current Assets	28.47	327.59	321.31	36.84	69.73
Total Current Assets	225.68	654.16	778.83	342.76	401.62
Property, Plant & Equipment	832.71	621.59	564.83	888.09	876.14
Long-Term Investments	-	-	-	0.18	0.04
Other Intangible Assets	0.19	0.21	0.19	0.28	0.37
Long-Term Deferred Tax Assets	7.29	8.55	12.31	13.85	9.2
Other Long-Term Assets	29.9	30.76	45.74	34.92	49.12
Total Assets	1,096	1,315	1,402	1,280	1,336
Accounts Payable	12.59	13.9	9.14	28.5	10.47
Accrued Expenses	7.33	12.88	11.05	11.8	17.22
Short-Term Debt	28	90	92	95	161
Current Portion of Long-Term Debt	26.18	30.98	238.29	66.66	18.47
Current Portion of Leases	0.52	1.14	0.98	1.37	1.51
Current Unearned Revenue	0.03	-	0.23	2.4	-
Other Current Liabilities	9.84	30.09	5.08	12.64	13.86
Total Current Liabilities	84.49	178.98	356.77	218.37	222.53
Long-Term Debt	19.43	45.41	85.7	330.94	433.22
Long-Term Leases	0.09	0.6	0.63	1.61	3.81
Long-Term Unearned Revenue	-	0.22	0.65	1.42	2.41
Long-Term Deferred Tax Liabilities	2.48	0.75	0.08	0.55	0.28
Total Liabilities	106.48	225.96	443.83	552.88	662.24
Common Stock	719.42	679.86	597.1	395.14	330.82
Additional Paid-In Capital	338.7	355.25	344.46	286.31	246.9
Retained Earnings	-55.26	26.31	4.3	61.32	105.98
Comprehensive Income & Other	-13.59	27.89	12.21	-15.56	-9.46
Shareholders' Equity	989.28	1,089	958.06	727.2	674.24
Total Liabilities & Equity	1,096	1,315	1,402	1,280	1,336
Total Debt	74.21	168.13	417.6	495.59	618.01
Net Cash (Debt)	57.96	85.45	-37.53	-300.41	-420.87
Net Cash Growth	-32.18%	-	-	-	-
Net Cash Per Share	0.81	1.19	-0.70	-7.76	-12.96
Filing Date Shares Outstanding	71.94	67.99	59.71	39.51	33.08
Total Common Shares Outstanding	71.94	67.99	59.71	39.51	33.08
Working Capital	141.19	475.19	422.07	124.39	179.09
Book Value Per Share	13.75	16.02	16.05	18.40	20.38
Tangible Book Value	989.09	1,089	957.88	726.92	673.88
Tangible Book Value Per Share	13.75	16.02	16.04	18.40	20.37
Land	401.07	401.07	401.07	401.07	400.92
Buildings	313.83	138.81	133.06	320.83	317.42
Machinery	304.77	187.52	177.46	291.48	256.69
Construction In Progress	1.56	51.76	-	0.24	1.42
Leasehold Improvements	51.75	25.83	25.31	54.72	53.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.